Life Molecular Imaging and SOFIE Expand Partnership to Distribute Neuraceq PET Imaging Agent
Neuraceq® is an FDA-approved imaging agent used to detect beta-amyloid plaques in the brains of adult patients with cognitive impairment undergoing evaluation for Alzheimer's disease and other cognitive decline causes.
Johnson & Johnson Receives FDA Approval for CARVYKTI for Multiple Myeloma Treatment
With this advancement, CARVYKTI® becomes the first and only B-cell maturation antigen (BCMA)-targeted therapy approved for multiple myeloma treatment as early as the first relapse.
CDL Nuclear Technologies Introduces New Mobile Cardiac PET/CT Trailer
This cutting-edge mobile solution is designed to revolutionize cardiac care by directly providing state-of-the-art cardiac PET/CT imaging services to medical facilities on their schedule.
The agreement was facilitated by the NS Pharma Innovation Research Partnering (IRP) team, located in Cambridge, MA.
Acumen Pharmaceuticals Join Hands with Lonza to Bolster Sabirnetug Production
Acumen Pharmaceuticals has signed a partnership agreement with Lonza, a global partner to the pharmaceutical, biotech, and nutraceutical markets.
Clario Acquires ArtiQ to Boost AI Use in Clinical Trials
Clario has recently acquired ArtiQ, an innovative software company dedicated to enhancing the diagnosis and monitoring of patients with respiratory conditions.
Alterome Therapeutics Bags USD 132 Million in Series B Financing
Alterome Therapeutics, Inc. has announced the closing of a USD 132 million Series B financing.
Aurigene Rolls Out AI and ML Assisted Drug Discovery Platform
Aurigene Pharmaceutical Services Ltd., a subsidiary of Dr Reddy’s Laboratories, has launched Aurigene. AI, an innovative platform integrating artificial intelligence.
Shimadzu Medical Systems USA Acquires California X-ray Imaging Services
CIS, headquartered in Vacaville, CA, has been a trusted provider of medical imaging products and services since 1992, serving the northern California and northern Nevada regions.
Lupin Appoints Dr. Ranjana Pathak as Chief Quality Officer
Bringing over three decades of industry experience to her new role, Dr. Pathak will lead Lupin's quality and regulatory compliance efforts across its global operations.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy